Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tarsus Pharmaceuticals (TARS) Other financing activities: 2019-2024

Historic Other financing activities for Tarsus Pharmaceuticals (TARS) over the last 4 years, with Dec 2024 value amounting to $3.5 million.

  • Tarsus Pharmaceuticals' Other financing activities was N/A to $39,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $3.0 million, marking a year-over-year change of. This contributed to the annual value of $3.5 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Tarsus Pharmaceuticals reported Other financing activities of $3.5 million as of FY2024, which was up 302.63% from $875,000 recorded in FY2022.
  • In the past 5 years, Tarsus Pharmaceuticals' Other financing activities registered a high of $3.5 million during FY2024, and its lowest value of $875,000 during FY2022.
  • Moreover, its 2-year median value for Other financing activities was $2.2 million (2022), whereas its average is $2.2 million.
  • Data for Tarsus Pharmaceuticals' Other financing activities shows a peak YoY surged of 1,319.77% (in 2020) over the last 5 years.
  • Yearly analysis of 3 years shows Tarsus Pharmaceuticals' Other financing activities stood at $2.4 million in 2020, then followed by $875,000 in 2022, then followed by $3.5 million in 2024.